By Jason Ma
Publication Date: 2026-03-15 17:50:00
In 2024, Sydney technology entrepreneur Paul Conyngham learned that his dog Rosie had cancer. But after the diagnosis was combated with chemotherapy and surgery, the tumors persisted and Rosie became sicker and sicker.
So he turned to AI and eventually developed a customized mRNA cancer vaccine with the help of Australian scientists. Most of Rosie’s tumors have shrunk and the dog is hunting rabbits again.
OpenAI’s ChatGPT suggested immunotherapy and referred Conyngham to the Ramacotti Center for Genomics at the University of New South Wales, according to a report in the journal Australian.
Although Conyngham does not have a medical background, he is an electrical and computer engineer and co-founder of Core Intelligence Technologies. He was also a director of the Data Science and AI Association of Australia.
After contacting the university, he convinced researchers there to help him and paid UNSW to sequence Rosie’s genome. Then he started looking into DNA.
“I went to ChatGPT and came across…
